Reducing the damage sustained by the heart during a myocardial infarction remains one of the major challenges in cardiology, ...
Among patients who are already taking statins, giving additional doses in the hours before CABG isn’t worthwhile, the StaRT-CABG trial shows. The 30-day rate of MACCE (a composite of all-cause ...
Transthyretin amyloid (ATTR) cardiomyopathy is a progressive and fatal disease caused by misfolded transthyretin. Despite advances in slowing disease progression, there is no available treatment that ...